Crosspoint Capital Strategies’s Amgen AMGN Stock Holding History

Crosspoint Capital Strategies’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,000	Closed	-$161K	–	152
2015 Q4	$161K	Sell	1,000 -5,749	-85%	-$904K	0.04%	257
2015 Q3	$934K	Sell	6,749 -2,209	-25%	-$348K	1.08%	17
2015 Q2	$1.38M	Sell	8,958 -297	-3%	-$47.6K	0.39%	51
2015 Q1	$1.48M	Buy	9,255 +1,706	+23%	+$269K	0.71%	39
2014 Q4	$1.2M	Buy	7,549 +6,459	+593%	+$1.01M	0.42%	71
2014 Q3	$153K	Buy	1,090 +100	+10%	+$13.1K	0.11%	127
2014 Q2	$121K	Buy	990 +700	+241%	+$81K	0.05%	174
2014 Q1	$36K	Hold	290	–	–	0.01%	292
2013 Q4	$37K	Buy	+290	New	+$33K	0.01%	291

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Crosspoint Capital Strategies's AMGN Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Amgen (AMGN) in Q1 2016, closing a stake of 1,000 shares — an estimated $161K sold.

Crosspoint Capital Strategies first reported a position in AMGN in Q4 2013 and held it in 9 quarters. The position peaked at $1.48M in Q1 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

Crosspoint Capital Strategies reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 1,000 Amgen shares in Q1 2016, an estimated $161K.
Crosspoint Capital Strategies first reported a position in Amgen in Q4 2013 and held it in 9 quarters.
Crosspoint Capital Strategies's Amgen position peaked at $1.48M in Q1 2015.
1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.